Despite the effects on the innate immune response during primary infection, anti–IL-10R administration caused a slight decrease (rather than the expected increase) in the numbers of Ag-experienced CD4+ T cells during the early phases of primary infection (Fig. 7A). The gene discussed is CD4; the disease is infection.